Bavencio, EMD Serono
First-Line Avelumab-Axitinib Combo Increases PFS for Patients With Advanced RCC
First-line treatment combining the immune checkpoint blocker avelumab (Bavencio, EMD Serono/Pfizer) with the ...
JANUARY 24, 2019
Bavencio Approved for Bladder Cancer
The drug was approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose ...
MAY 10, 2017
Load more